Nexobrid TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: anacaulase-bcdb
Pack: Nexobrid (1 x 4.85 g vial, 1 x 50 g inert diluent bottle), 1 pack
Brand name
(ARTG)
: NEXOBRID anacaulase-bcdb 4.85 g powder vial with diluent gel bottle composite packConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
NEXOBRID is indicated for eschar removal in adults and paediatric patients with deep partial thickness (DPT) and/or full thickness (FT) thermal burns.,For further information on acceptable burn types, see Section 4.4 Special Warnings and Precautions.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Powder
- Topical
- Off-white to light tan lyophilized powder in a glass vial
Component :
- Diluent, not applicable
- Topical
- Sterile, clear gel.
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Store Upright
- Store in Original Container
- See Product information for shelf life
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 vial of powder and 1 bottle of gel. pack
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
